En bloc resection for nonmuscle-invasive bladder cancer: selecting a proper laser.


Journal

Current opinion in urology
ISSN: 1473-6586
Titre abrégé: Curr Opin Urol
Pays: United States
ID NLM: 9200621

Informations de publication

Date de publication:
01 Mar 2022
Historique:
pubmed: 27 12 2021
medline: 30 4 2022
entrez: 26 12 2021
Statut: ppublish

Résumé

To discuss the most recent surgical lasers that have been made available to us and to evaluate their potential in performing en bloc resection of nonmuscle invasive bladder cancer. Laser en bloc resection of bladder tumors (ERBT) can be performed with a number of laser systems including Ho:YAG, GreenLight, diode, Tm:YAG and thulium fiber lasers (TFL). The data that is currently available suggests that the water-targeting devices (utilizing water as a primary chromophore - Ho:YAG, Tm:YAG, TFL) may have a number of advantages over hemoglobin-targeting systems (potassium titanyl phosphate:YAG, lithium triborate:YAG). One recent addition to the surgical armamentarium Moses effect enhanced Ho:YAG and the TFL (being able to work both in quasi-continuous and SuperPulsed modes) necessitates careful discussion and comparison with the other available devices. The majority of available lasers have proven to be safe to use and compared to electrocautery allow for lower rates of obturator nerve reflex and result in fewer bleeding complications. The minimal penetration depth and decreased peak power of Tm:YAG and TFLs render them the devices of choice when it comes to ERBT. Unfortunately, more studies on ERBT with TFL are needed in order for us to make a sound assessment of the respective pros and cons.

Identifiants

pubmed: 34954702
doi: 10.1097/MOU.0000000000000968
pii: 00042307-202203000-00011
doi:

Substances chimiques

Water 059QF0KO0R
Thulium 8RKC5ATI4P

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

173-178

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Références

Taratkin M, Kovalenko A, Laukhtina E, et al. Ex vivo study of Ho: YAG and thulium fiber lasers for soft tissue surgery: which laser for which case? Lasers Med Sci 2020; 1–6
Hurle R, Casale P, Lazzeri M, et al. En bloc re-resection of high-risk NMIBC after en bloc resection: results of a multicenter observational study. World J Urol 2020; 38:703–708.
Ukai R, Kawashita E, Ikeda H. A new technique for transurethral resection of superficial bladder tumor in 1 piece. J Urol 2000; 163:878–879.
Hurle R, Lazzeri M, Colombo P, et al. En Bloc’ resection of nonmuscle invasive bladder cancer: a prospective single-center study. Urology 2016; 90:126–130.
Kramer MW, Altieri V, Hurle R, et al. Current evidence of transurethral en-bloc resection of nonmuscle invasive bladder cancer. Eur Urol Focus 2017; 3:567–576.
Kramer MW, Rassweiler JJ, Klein J, et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 2015; 33:1937–1943.
Venkatramani V, Panda A, Manojkumar R, Kekre NS. Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial. J Urol 2014; 191:1703–1707.
Babjuk M, Burger M, Capoun O, et al. European Association of Urology guidelines on non–muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2021.
Saito S. Transurethral en bloc resection of bladder tumors. J Urol 2001; 166:2148–2150.
Hashem A, Mosbah A, El-Tabey NA, et al. Holmium laser en-bloc resection versus conventional transurethral resection of bladder tumors for treatment of nonmuscle-invasive bladder cancer: a randomized clinical trial. Eur Urol Focus 2020; 7:1035–1043.
Maheshwari PN, Arora AM, Sane MS, Jadhao VG. Safety, feasibility, and quality of holmium laser en-bloc resection of nonmuscle invasive bladder tumors-a single-center experience. Indian J Urol 2020; 36:106–111.
Kavoussi NL, Nimmagadda N, Robles J, et al. MOSESTM technology for holmium laser enucleation of the prostate: a prospective double-blind randomized controlled trial. J Urol 2021; 206:104–108.
Enikeev D, Shariat SF, Taratkin M, Glybochko P. The changing role of lasers in urologic surgery. Curr Opin Urol 2020; 30:24–29.
Lai S, Peng P, Diao T, et al. Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: An updated systematic review and meta-analysis of randomised controlled trials and prospective studies. BMJ Open 2019; 9:e028855.
Herrmann TRW, Liatsikos EN, Nagele U, et al. EAU guidelines on laser technologies. Eur Urol 2012; 61:783–795.
Wendt-Nordahl G, Huckele S, Honeck P, et al. Systematic evaluation of a recently introduced 2-(m continuous-wave thulium laser for vaporesection of the prostate. J Endourol 2008; 22:1041–1045.
He D, Fan J, Wu K, et al. Novel green-light KTP laser en bloc enucleation for nonmuscle-invasive bladder cancer: Technique and initial clinical experience. J Endourol 2014; 28:975–979.
Chen J, Zhao Y, Wang S, et al. Green-light laser en bloc resection for primary nonmuscle-invasive bladder tumor versus transurethral electroresection: a prospective, nonrandomized two-center trial with 36-month follow-up. Lasers Surg Med 2016; 48:859–865.
Fan J, Wu K, Zhang N, et al. Green-light laser en bloc resection versus conventional transurethral resection for initial nonmuscle-invasive bladder cancer: a randomized controlled trial. Int J Urol 2021; 28:855–860.
Chen J, Zhao Y, Wang S, et al. Green-light laser en bloc resection for primary nonmuscle-invasive bladder tumor versus transurethral electroresection: A prospective, nonrandomized two-center trial with 36-month follow-up. Lasers Surg Med 2016; 48:859–865.
Lee J, Gianduzzo TRJ. Advances in laser technology in urology. Urol Clin N Am 2009; 36:189–198.
Hamblin MR, Huang YY. Handbook of photomedicine. Handbook of Photomedicine. 2013; Boca Raton: CRC Press, 1–829 p.
Jelinkova H. Lasers For medical applications: diagnostics, therapy and surgery. 2013; Amsterdam: Elsevier Science, 825 p.
Xia S-J, Zhuo J, Sun X-W, et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 2008; 53:382–390.
Wolters M, Kramer MW, Becker JU, et al. Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: Early experience. World J Urol 2011; 29:429–432.
Migliari R, Buffardi A, Ghabin H. Thulium laser endoscopic en bloc enucleation of nonmuscle-invasive bladder cancer. J Endourol 2015; 9:1258–1262.
Chen X, Liao J, Chen L, et al. En bloc transurethral resection with 2-micron continuous-wave laser for primary nonmuscle-invasive bladder cancer: a randomized controlled trial. World J Urol 2015; 33:989–995.
Teichmann H-O, Herrmann TR, Bach T. Technical aspects of lasers in urology. World J Urol 2007; 25:221–225.
Huusmann S, Wolters M, Kramer MW, et al. Tissue damage by laser radiation: an in vitro comparison between Tm:YAG and Ho:YAG laser on a porcine kidney model. Springerplus 2016; 5:266–273.
Long G, Zhang Y, Sun G, et al. Safety and efficacy of thulium laser resection of bladder tumors versus transurethral resection of bladder tumors: a systematic review and meta-analysis. Lasers Med Sci 2021; 36:1807–1816.
Enikeev D, Taratkin M, Azilgareeva C, Glybochko P. Knowing the inside of a laser. Arch Esp Urol 2020; 73:665–674.
Migliari R, Buffardi A, Ghabin H. Thulium laser endoscopic en bloc enucleation of nonmuscle-invasive bladder cancer. J Endourol 2015; 29:1258–1262.
Enikeev D, Traxer O, Taratkin M, et al. A review of thulium-fiber laser in stone lithotripsy and soft tissue surgery. Curr Opin Urol 2020; 30:853–860.
Becker B, Enikeev D, Glybochko P, et al. Effect of optical fiber diameter and laser emission mode (cw vs pulse) on tissue damage profile using 1.94 μm Tm:fiber lasers in a porcine kidney model. World J Urol 2020; 38:1563–1568.
Becker B, Enikeev D, Netsch C, et al. Comparative analysis of vaporization and coagulation properties of a hybrid laser (combination of a thulium and blue diode laser) vs thulium and Ho:YAG lasers: potential applications in endoscopic enucleation of the prostate. J Endourol 2020; 34:862–867.
Enikeev D, Okhunov Z, Rapoport L, et al. Novel thulium fiber laser for enucleation of prostate: a retrospective comparison with open simple prostatectomy. J Endourol 2019; 33:16–21.
Enikeev D, Glybochko P, Rapoport L, et al. Impact of endoscopic enucleation of the prostate with thulium fiber laser on the erectile function. BMC Urol 2018; 18:87–92.
Enikeev D, Netsch C, Rapoport L, et al. Novel thulium fiber laser for endoscopic enucleation of the prostate: A prospective comparison with conventional transurethral resection of the prostate. Int J Urol 2019; 26:1138–1143.
Enikeev D, Taratkin M, Margulis V, et al. Safety and short-term oncological outcomes of thulium fiber laser en bloc resection of non-muscle-invasive bladder cancer: a prospective non-randomized Phase II trial. Bladder Cancer 2020; 6:201–210.

Auteurs

Dmitry Enikeev (D)

Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Marek Babjuk (M)

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Department of Urology, Second Faculty of Medicine and Hospital Motol, Charles University, Prague, Czech Republic.

Anastasia Shpikina (A)

Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Shahrokh Shariat (S)

Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Department of Urology, Second Faculty of Medicine and Hospital Motol, Charles University, Prague, Czech Republic.
Department of Urology, Weill Cornell Medical College, New York, New York.
Department of Urology, University of Texas Southwestern, Dallas, Texas, USA.

Petr Glybochko (P)

Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH